GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
357
c/glp1eu·posted 2 months ago by u/oskar_malinowski

[Discussion] the EU advice in here is 3 years out of date

Discussion Sourced ×6

Thinking out loud about this: the EU advice in here is 3 years out of date.

3 years — those are the numbers, and they are the ones I am willing to defend.

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

Compared prices across two neighbouring countries and found the difference was mostly pack size once I normalised it.

That is everything I have. The rest is opinion and I have tried to keep it out.

435 up / 78 down85% upvoted26 commentsid 1wcyum5 May 2026

26 comments

18 in this archive, depth 4

best — the order this archive was captured in

u/signe_villalobos60 points·2 months ago

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/arne_ndiaye30 points·2 months ago

Are you comparing the same presentation, or different pack sizes?

replysharereportpermalink
u/wanjiru_ramos42 points·2 months ago

a prescription from one member state is not automatically valid in another

replysharereportpermalink
u/plateau_patrol35 points·2 months ago

reimbursement is national, not European, and that is the whole board

replysharereportpermalink
u/honest_syringe_maybe21 points·2 months ago

Is the prescription from the same country as the pharmacy?

replysharereportpermalink
u/patient_labslip_log8 points·2 months ago

reimbursement is national, not European, and that is the whole board

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
u/solene_ilunga4 points·2 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
u/oskar_malinowskiOP-27 points·2 months ago

The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.

replysharereportpermalink
u/diego_iyer1 point·2 months ago

Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.

replysharereportpermalink
u/cesar_oyelaran1 point·2 months ago

keep the prescription and the receipt, both matter for claims

replysharereportpermalink
u/nordic_pricingMOD41 points·2 months ago

Pharmacy link removed. No links of any kind here, in any country, for any reason.

replysharereportpermalink
u/renal_outcomes_rnephro-curious14 points·2 months ago

Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.

replysharereportpermalink
u/amira_dumitru4 points·2 months ago

Apotheke pricing and pharmacy pricing elsewhere are different systems

replysharereportpermalink
u/ewan_tulloch1 point·2 months ago

private pricing varies enormously between neighbouring countries

replysharereportpermalink
u/noor_ivaturi24 points·2 months ago

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

replysharereportpermalink
u/ingrid_correia16 points·2 months ago·edited

What pack size is that price for?

replysharereportpermalink
u/nikhil_asante8 points·2 months ago·edited

What pack size is that price for?

Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.

replysharereportpermalink
u/adaeze_cabrera3 points·2 months ago

pack sizes differ, so per-month comparisons need care

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.